Scientific Posters , Clinical Trial Manufacturing , Formulation Development , First-in-Human

How do I quickly develop first-in-human (FIH) dosage forms and avoid CMC delays whilst achieving proof-of-concept (POC)?

Overview

Download Quotient Sciences', 'How do I quickly develop first-in-human (FIH) dosage forms and avoid CMC delays whilst achieving proof-of-concept (POC)?'.

Our scientific poster includes the following:

  • Choosing the appropriate dosage form for first-in-human clinical trials
  • Deciding between a pharmacy preparation or GMP manufacturing
  • Bridging to robust and scalable Phase II drug products
  • Flexible and adaptive clinical manufacturing strategies for patient trials
  • Integrating pharmaceutical sciences and clinical testing
Download